QYUNS-B: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE DEVELOPMENT AND POTENTIAL COMMERCIALIZATION PARTNERSHIP OF QX005N WITH ZHONGMEI HUADONG
QYUNS-B: DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OFWEALTH MANAGEMENT PRODUCTS
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
QYUNS-B: DISCLOSEABLE TRANSACTIONS IN RELATION TOSUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
QYUNS-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL DATA OF QX005N INJECTION FOR TREATMENT OF PRURIGO NODULARIS (PN) RELEASED AT THE 29TH ANNUAL MEETING OF CHINESE SOCIETY OF DERMATOLOGY
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
QYUNS-B: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 31, 2024
QYUNS-B: VOLUNTARY ANNOUNCEMENTFIRST SUBJECT ENROLLMENT FORQX005N PHASE III CLINICAL TRIAL FOR THE TREATMENT OF PRURIGONODULARIS
QYUNS-B: CLARIFICATION ANNOUNCEMENT SUPPLEMENTAL NOTICE AND REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024
QYUNS-B: REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024
QYUNS-B: SUPPLEMENTAL NOTICE OF 2023 ANNUAL GENERAL MEETING
QYUNS-B: VOLUNTARY ANNOUNCEMENTQYUNS OBTAINED IND CLEARANCE FOR QX013N FOR TREATMENT OFCHRONIC SPONTANEOUS URTICARIA IN CHINA
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
QYUNS-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETINGTO BE HELD ON FRIDAY, MAY 31, 2024
QYUNS-B: NOTICE OF 2023 ANNUAL GENERAL MEETING
QYUNS-B: (1) 2023 WORK REPORT OF THE BOARD(2) 2023 WORK REPORT OF THE BOARD OF SUPERVISORS(3) 2023 ANNUAL REPORT;(4) 2023 PROFIT DISTRIBUTION PLAN;(5) 2024 REMUNERATION SCHEME FOR DIRECTORS AND SUPERVISORS;(6) ENGAGEMENT OF THE AUDITOR FOR 2024;(7) PROPOSED G
QYUNS-B: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
QYUNS-B: 2023 ANNUAL REPORT
QYUNS-B: VOLUNTARY ANNOUNCEMENTBUSINESS UPDATE
QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
No Data